On this page
Apollo Hospitals plans four new hospitals and 5,800 beds over five years
Apollo Hospitals reported Q1FY27 profit of Rs 581 crore and revenue of Rs 7,044 crore, both in line with estimates. It announced four hospitals and plans to add over 5,800 beds in five years, while brokerages remained divided on valuation.
One email each morning: the day’s top moves in Indian retail, why each matters and what to watch. Free. Stop any time.
The numbers
Figures from NDTV Profit,
| Q1FY27 consolidated net profit: | Rs 581 crore, up 34.2% year-on-year |
|---|---|
| Q1FY27 revenue: | Rs 7,044 crore, up 20.6% year-on-year |
| Prior-year net profit: | Rs 433 crore |
| Prior-year revenue: | Rs 5,842 crore |
| Hospital EBITDA growth: | 25% like-for-like |
Why it matters to operators and investors
Apollo’s planned four hospitals and 5,800 additional beds signal a major capacity buildout, requiring disciplined execution across staffing, clinical quality and utilization.
What to watch next
- Detailed city-wise location plan, capex guidance and commissioning schedule for the four hospitals and 5,800 beds.
- Occupancy, average revenue per occupied bed, payer mix and EBITDA-margin trends at existing hospitals.
- Net debt, operating cash flow and any equity or partnership funding tied to the expansion.
- Doctor recruitment, nursing availability and wage-cost inflation.
- Regulatory approvals, land acquisition progress and construction-cost inflation.
The counter-case
The case against this reading — not reported by the source.
The expansion plan could dilute returns if bed additions outpace demand, especially in competitive urban markets where pricing power is constrained. Adding 5,800 beds requires substantial capital, clinician hiring and ramp-up spending; new facilities may depress margins and return on capital for several years. Strong Q1 profit growth may not be sufficient evidence that the larger pipeline can be funded and executed without leverage, dilution or slower investment in existing assets.
The source
First seen